Response To 1st-Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry
Knauf W, Abenhardt W, Engel E et al.
Key Points:
In this study authors investigated effectiveness of BR and FCR in unselected pts with CLL.
None of tested parameters (age, sex, type of regimen, tumour stage ect.) had significant impact on response rate.
Median observation time was 17 months (maximum 40 mos.
Implications:
- In previously untreated pts with CLL response rates to 1st-line treatment with BR or FCR comparable.
View the original abstract on the ASH website.
